nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluticasone Propionate—PLA2G4A—Orlistat—type 2 diabetes mellitus	0.21	0.5	CbGbCtD
Fluticasone Propionate—NR3C1—type 2 diabetes mellitus	0.209	0.633	CbGaD
Fluticasone Propionate—CYP3A4—type 2 diabetes mellitus	0.121	0.367	CbGaD
Fluticasone Propionate—CYP3A7—Nateglinide—type 2 diabetes mellitus	0.0294	0.0699	CbGbCtD
Fluticasone Propionate—CYP3A7-CYP3A51P—Nateglinide—type 2 diabetes mellitus	0.0294	0.0699	CbGbCtD
Fluticasone Propionate—CYP3A5—Nateglinide—type 2 diabetes mellitus	0.0221	0.0525	CbGbCtD
Fluticasone Propionate—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0176	0.0419	CbGbCtD
Fluticasone Propionate—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0157	0.0373	CbGbCtD
Fluticasone Propionate—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0144	0.0341	CbGbCtD
Fluticasone Propionate—CYP3A5—Losartan—type 2 diabetes mellitus	0.0136	0.0324	CbGbCtD
Fluticasone Propionate—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0126	0.0298	CbGbCtD
Fluticasone Propionate—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0114	0.027	CbGbCtD
Fluticasone Propionate—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0086	0.0205	CbGbCtD
Fluticasone Propionate—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00825	0.0196	CbGbCtD
Fluticasone Propionate—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00825	0.0196	CbGbCtD
Fluticasone Propionate—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0078	0.0185	CbGbCtD
Fluticasone Propionate—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00581	0.0138	CbGbCtD
Fluticasone Propionate—CYP3A4—Losartan—type 2 diabetes mellitus	0.00532	0.0126	CbGbCtD
Fluticasone Propionate—PGR—artery—type 2 diabetes mellitus	0.00165	0.0793	CbGeAlD
Fluticasone Propionate—NR3C1—nerve—type 2 diabetes mellitus	0.000947	0.0454	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—nephron tubule—type 2 diabetes mellitus	0.000899	0.0431	CbGeAlD
Fluticasone Propionate—SERPINA6—nephron tubule—type 2 diabetes mellitus	0.000843	0.0404	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—cortex of kidney—type 2 diabetes mellitus	0.00077	0.0369	CbGeAlD
Fluticasone Propionate—PLA2G4A—cardiovascular system—type 2 diabetes mellitus	0.000761	0.0365	CbGeAlD
Fluticasone Propionate—SERPINA6—kidney—type 2 diabetes mellitus	0.000741	0.0355	CbGeAlD
Fluticasone Propionate—NR3C2—retina—type 2 diabetes mellitus	0.000731	0.0351	CbGeAlD
Fluticasone Propionate—PLA2G4A—cortex of kidney—type 2 diabetes mellitus	0.000725	0.0348	CbGeAlD
Fluticasone Propionate—SERPINA6—cortex of kidney—type 2 diabetes mellitus	0.000722	0.0346	CbGeAlD
Fluticasone Propionate—NR3C2—nephron tubule—type 2 diabetes mellitus	0.000689	0.033	CbGeAlD
Fluticasone Propionate—PLA2G4A—adipose tissue—type 2 diabetes mellitus	0.000671	0.0322	CbGeAlD
Fluticasone Propionate—NR3C2—cardiovascular system—type 2 diabetes mellitus	0.000618	0.0297	CbGeAlD
Fluticasone Propionate—NR3C2—kidney—type 2 diabetes mellitus	0.000605	0.029	CbGeAlD
Fluticasone Propionate—PLA2G4A—Glyburide—Glimepiride—type 2 diabetes mellitus	0.000603	0.17	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Glyburide—Tolazamide—type 2 diabetes mellitus	0.000603	0.17	CbGdCrCtD
Fluticasone Propionate—NR3C2—cortex of kidney—type 2 diabetes mellitus	0.000589	0.0283	CbGeAlD
Fluticasone Propionate—CYP3A7—liver—type 2 diabetes mellitus	0.000587	0.0282	CbGeAlD
Fluticasone Propionate—PGR—cardiovascular system—type 2 diabetes mellitus	0.000575	0.0276	CbGeAlD
Fluticasone Propionate—PLA2G4A—Glyburide—Gliclazide—type 2 diabetes mellitus	0.000572	0.161	CbGdCrCtD
Fluticasone Propionate—PLA2G4A—Glyburide—Glipizide—type 2 diabetes mellitus	0.000572	0.161	CbGdCrCtD
Fluticasone Propionate—NR3C2—adipose tissue—type 2 diabetes mellitus	0.000545	0.0262	CbGeAlD
Fluticasone Propionate—PLA2G4A—Glyburide—Chlorpropamide—type 2 diabetes mellitus	0.000523	0.148	CbGdCrCtD
Fluticasone Propionate—PGR—adipose tissue—type 2 diabetes mellitus	0.000507	0.0243	CbGeAlD
Fluticasone Propionate—CYP3A7-CYP3A51P—liver—type 2 diabetes mellitus	0.0005	0.024	CbGeAlD
Fluticasone Propionate—SERPINA6—liver—type 2 diabetes mellitus	0.000468	0.0225	CbGeAlD
Fluticasone Propionate—CYP3A5—islet of Langerhans—type 2 diabetes mellitus	0.000462	0.0222	CbGeAlD
Fluticasone Propionate—NR3C1—islet of Langerhans—type 2 diabetes mellitus	0.000459	0.022	CbGeAlD
Fluticasone Propionate—PLA2G4A—Enalapril—Nateglinide—type 2 diabetes mellitus	0.000417	0.118	CbGdCrCtD
Fluticasone Propionate—NR3C2—liver—type 2 diabetes mellitus	0.000382	0.0183	CbGeAlD
Fluticasone Propionate—CYP3A5—nephron tubule—type 2 diabetes mellitus	0.000372	0.0178	CbGeAlD
Fluticasone Propionate—NR3C1—nephron tubule—type 2 diabetes mellitus	0.000369	0.0177	CbGeAlD
Fluticasone Propionate—NR3C1—cardiovascular system—type 2 diabetes mellitus	0.000332	0.0159	CbGeAlD
Fluticasone Propionate—CYP3A5—kidney—type 2 diabetes mellitus	0.000327	0.0157	CbGeAlD
Fluticasone Propionate—CYP3A5—pancreas—type 2 diabetes mellitus	0.000325	0.0156	CbGeAlD
Fluticasone Propionate—NR3C1—kidney—type 2 diabetes mellitus	0.000325	0.0156	CbGeAlD
Fluticasone Propionate—NR3C1—pancreas—type 2 diabetes mellitus	0.000322	0.0155	CbGeAlD
Fluticasone Propionate—CYP3A5—cortex of kidney—type 2 diabetes mellitus	0.000319	0.0153	CbGeAlD
Fluticasone Propionate—NR3C1—cortex of kidney—type 2 diabetes mellitus	0.000316	0.0152	CbGeAlD
Fluticasone Propionate—CYP3A5—adipose tissue—type 2 diabetes mellitus	0.000295	0.0141	CbGeAlD
Fluticasone Propionate—NR3C1—adipose tissue—type 2 diabetes mellitus	0.000293	0.014	CbGeAlD
Fluticasone Propionate—PLA2G4A—Enalapril—Ramipril—type 2 diabetes mellitus	0.000254	0.0716	CbGdCrCtD
Fluticasone Propionate—CYP3A4—kidney—type 2 diabetes mellitus	0.000245	0.0118	CbGeAlD
Fluticasone Propionate—Difluprednate—NR3C1—type 2 diabetes mellitus	0.000219	0.0483	CrCbGaD
Fluticasone Propionate—Clocortolone—NR3C1—type 2 diabetes mellitus	0.000213	0.0468	CrCbGaD
Fluticasone Propionate—Prednicarbate—NR3C1—type 2 diabetes mellitus	0.000213	0.0468	CrCbGaD
Fluticasone Propionate—CYP3A5—liver—type 2 diabetes mellitus	0.000207	0.00991	CbGeAlD
Fluticasone Propionate—NR3C1—liver—type 2 diabetes mellitus	0.000205	0.00984	CbGeAlD
Fluticasone Propionate—Diflorasone—NR3C1—type 2 diabetes mellitus	0.000201	0.0443	CrCbGaD
Fluticasone Propionate—Desoximetasone—NR3C1—type 2 diabetes mellitus	0.000196	0.0432	CrCbGaD
Fluticasone Propionate—Flumethasone Pivalate—NR3C1—type 2 diabetes mellitus	0.000169	0.0372	CrCbGaD
Fluticasone Propionate—Halobetasol Propionate—NR3C1—type 2 diabetes mellitus	0.000166	0.0366	CrCbGaD
Fluticasone Propionate—CYP3A4—liver—type 2 diabetes mellitus	0.000155	0.00744	CbGeAlD
Fluticasone Propionate—Amcinonide—NR3C1—type 2 diabetes mellitus	0.000155	0.034	CrCbGaD
Fluticasone Propionate—Fluticasone furoate—NR3C1—type 2 diabetes mellitus	0.000152	0.0334	CrCbGaD
Fluticasone Propionate—Mometasone—NR3C1—type 2 diabetes mellitus	0.000147	0.0324	CrCbGaD
Fluticasone Propionate—Rimexolone—NR3C1—type 2 diabetes mellitus	0.000145	0.032	CrCbGaD
Fluticasone Propionate—Beclomethasone—NR3C1—type 2 diabetes mellitus	0.000137	0.0302	CrCbGaD
Fluticasone Propionate—Fluocinonide—NR3C1—type 2 diabetes mellitus	0.000137	0.0302	CrCbGaD
Fluticasone Propionate—Fluocinolone Acetonide—NR3C1—type 2 diabetes mellitus	0.000133	0.0293	CrCbGaD
Fluticasone Propionate—Alclometasone—NR3C1—type 2 diabetes mellitus	0.000133	0.0293	CrCbGaD
Fluticasone Propionate—Flunisolide—NR3C1—type 2 diabetes mellitus	0.00013	0.0286	CrCbGaD
Fluticasone Propionate—Clobetasol propionate—NR3C1—type 2 diabetes mellitus	0.00013	0.0286	CrCbGaD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.00013	0.000869	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.00013	0.000868	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.000129	0.000866	CcSEcCtD
Fluticasone Propionate—Chest pain—Orlistat—type 2 diabetes mellitus	0.000129	0.000864	CcSEcCtD
Fluticasone Propionate—Anxiety—Orlistat—type 2 diabetes mellitus	0.000129	0.000861	CcSEcCtD
Fluticasone Propionate—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000128	0.00086	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000128	0.000858	CcSEcCtD
Fluticasone Propionate—Paramethasone—NR3C1—type 2 diabetes mellitus	0.000128	0.0282	CrCbGaD
Fluticasone Propionate—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000128	0.000856	CcSEcCtD
Fluticasone Propionate—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000128	0.000855	CcSEcCtD
Fluticasone Propionate—Discomfort—Orlistat—type 2 diabetes mellitus	0.000127	0.000854	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Losartan—type 2 diabetes mellitus	0.000127	0.000853	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000127	0.000849	CcSEcCtD
Fluticasone Propionate—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000126	0.000845	CcSEcCtD
Fluticasone Propionate—Malaise—Metformin—type 2 diabetes mellitus	0.000126	0.000844	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000126	0.000843	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000125	0.000841	CcSEcCtD
Fluticasone Propionate—Vomiting—Glipizide—type 2 diabetes mellitus	0.000125	0.00084	CcSEcCtD
Fluticasone Propionate—Oedema—Valsartan—type 2 diabetes mellitus	0.000125	0.000839	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000125	0.000839	CcSEcCtD
Fluticasone Propionate—Fluorometholone—NR3C1—type 2 diabetes mellitus	0.000125	0.0275	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000125	0.000838	CcSEcCtD
Fluticasone Propionate—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000125	0.000837	CcSEcCtD
Fluticasone Propionate—Infection—Valsartan—type 2 diabetes mellitus	0.000124	0.000833	CcSEcCtD
Fluticasone Propionate—Rash—Glipizide—type 2 diabetes mellitus	0.000124	0.000833	CcSEcCtD
Fluticasone Propionate—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.000124	0.000832	CcSEcCtD
Fluticasone Propionate—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000124	0.000832	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000124	0.000832	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.000124	0.000831	CcSEcCtD
Fluticasone Propionate—Erythema—Losartan—type 2 diabetes mellitus	0.000124	0.000831	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000124	0.000829	CcSEcCtD
Fluticasone Propionate—Oedema—Orlistat—type 2 diabetes mellitus	0.000124	0.000829	CcSEcCtD
Fluticasone Propionate—Headache—Glipizide—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Fluticasone Propionate—Tremor—Irbesartan—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Fluticasone Propionate—Palpitations—Metformin—type 2 diabetes mellitus	0.000123	0.000827	CcSEcCtD
Fluticasone Propionate—Infection—Orlistat—type 2 diabetes mellitus	0.000123	0.000823	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000123	0.000822	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000122	0.000819	CcSEcCtD
Fluticasone Propionate—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000122	0.000815	CcSEcCtD
Fluticasone Propionate—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000122	0.000815	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000121	0.000814	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000121	0.000813	CcSEcCtD
Fluticasone Propionate—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000121	0.000813	CcSEcCtD
Fluticasone Propionate—Agitation—Irbesartan—type 2 diabetes mellitus	0.000121	0.000811	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—NR3C1—type 2 diabetes mellitus	0.000121	0.0266	CrCbGaD
Fluticasone Propionate—Hypertension—Metformin—type 2 diabetes mellitus	0.000121	0.000808	CcSEcCtD
Fluticasone Propionate—Urticaria—Glyburide—type 2 diabetes mellitus	0.000121	0.000808	CcSEcCtD
Fluticasone Propionate—Angioedema—Irbesartan—type 2 diabetes mellitus	0.00012	0.000807	CcSEcCtD
Fluticasone Propionate—Skin disorder—Orlistat—type 2 diabetes mellitus	0.00012	0.000805	CcSEcCtD
Fluticasone Propionate—Connective tissue disorder—Ramipril—type 2 diabetes mellitus	0.00012	0.000804	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.00012	0.000804	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Losartan—type 2 diabetes mellitus	0.000119	0.000799	CcSEcCtD
Fluticasone Propionate—Chest pain—Metformin—type 2 diabetes mellitus	0.000119	0.000797	CcSEcCtD
Fluticasone Propionate—Malaise—Irbesartan—type 2 diabetes mellitus	0.000119	0.000796	CcSEcCtD
Fluticasone Propionate—Headache—Pioglitazone—type 2 diabetes mellitus	0.000118	0.000793	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000118	0.000791	CcSEcCtD
Fluticasone Propionate—Discomfort—Metformin—type 2 diabetes mellitus	0.000117	0.000787	CcSEcCtD
Fluticasone Propionate—Nausea—Glipizide—type 2 diabetes mellitus	0.000117	0.000785	CcSEcCtD
Fluticasone Propionate—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000117	0.000784	CcSEcCtD
Fluticasone Propionate—Vision blurred—Losartan—type 2 diabetes mellitus	0.000117	0.000783	CcSEcCtD
Fluticasone Propionate—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000117	0.000781	CcSEcCtD
Fluticasone Propionate—Pain—Gliclazide—type 2 diabetes mellitus	0.000116	0.000781	CcSEcCtD
Fluticasone Propionate—Tremor—Losartan—type 2 diabetes mellitus	0.000116	0.000779	CcSEcCtD
Fluticasone Propionate—Rash—Glimepiride—type 2 diabetes mellitus	0.000116	0.000777	CcSEcCtD
Fluticasone Propionate—Dexamethasone—CYP11A1—type 2 diabetes mellitus	0.000116	0.0255	CrCbGaD
Fluticasone Propionate—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000116	0.000776	CcSEcCtD
Fluticasone Propionate—Rash—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000775	CcSEcCtD
Fluticasone Propionate—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000116	0.000774	CcSEcCtD
Fluticasone Propionate—Headache—Glimepiride—type 2 diabetes mellitus	0.000115	0.000772	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000115	0.000771	CcSEcCtD
Fluticasone Propionate—Cough—Irbesartan—type 2 diabetes mellitus	0.000115	0.000771	CcSEcCtD
Fluticasone Propionate—Headache—Sitagliptin—type 2 diabetes mellitus	0.000115	0.00077	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000114	0.000764	CcSEcCtD
Fluticasone Propionate—Agitation—Losartan—type 2 diabetes mellitus	0.000114	0.000764	CcSEcCtD
Fluticasone Propionate—Oedema—Metformin—type 2 diabetes mellitus	0.000114	0.000764	CcSEcCtD
Fluticasone Propionate—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000114	0.000762	CcSEcCtD
Fluticasone Propionate—Clobetasol propionate—CYP1A2—type 2 diabetes mellitus	0.000114	0.025	CrCbGaD
Fluticasone Propionate—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000114	0.000761	CcSEcCtD
Fluticasone Propionate—Angioedema—Losartan—type 2 diabetes mellitus	0.000113	0.000759	CcSEcCtD
Fluticasone Propionate—Infection—Metformin—type 2 diabetes mellitus	0.000113	0.000759	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.000113	0.000755	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000112	0.000752	CcSEcCtD
Fluticasone Propionate—Chest pain—Irbesartan—type 2 diabetes mellitus	0.000112	0.000752	CcSEcCtD
Fluticasone Propionate—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.000112	0.000752	CcSEcCtD
Fluticasone Propionate—Malaise—Losartan—type 2 diabetes mellitus	0.000112	0.000749	CcSEcCtD
Fluticasone Propionate—Anxiety—Irbesartan—type 2 diabetes mellitus	0.000112	0.000749	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000112	0.000749	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000112	0.000749	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000112	0.000748	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000111	0.000747	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000111	0.000746	CcSEcCtD
Fluticasone Propionate—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000111	0.000743	CcSEcCtD
Fluticasone Propionate—Skin disorder—Metformin—type 2 diabetes mellitus	0.000111	0.000742	CcSEcCtD
Fluticasone Propionate—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000739	CcSEcCtD
Fluticasone Propionate—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.00011	0.000738	CcSEcCtD
Fluticasone Propionate—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.00011	0.000735	CcSEcCtD
Fluticasone Propionate—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.00011	0.000735	CcSEcCtD
Fluticasone Propionate—Palpitations—Losartan—type 2 diabetes mellitus	0.00011	0.000734	CcSEcCtD
Fluticasone Propionate—Nausea—Glimepiride—type 2 diabetes mellitus	0.000109	0.000732	CcSEcCtD
Fluticasone Propionate—Arrhythmia—Ramipril—type 2 diabetes mellitus	0.000109	0.000731	CcSEcCtD
Fluticasone Propionate—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000109	0.00073	CcSEcCtD
Fluticasone Propionate—Cough—Losartan—type 2 diabetes mellitus	0.000108	0.000725	CcSEcCtD
Fluticasone Propionate—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000108	0.000725	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000108	0.000722	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000108	0.000722	CcSEcCtD
Fluticasone Propionate—Oedema—Irbesartan—type 2 diabetes mellitus	0.000108	0.000721	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000108	0.000721	CcSEcCtD
Fluticasone Propionate—Pruritus—Glyburide—type 2 diabetes mellitus	0.000107	0.000719	CcSEcCtD
Fluticasone Propionate—Mental disorder—Ramipril—type 2 diabetes mellitus	0.000107	0.000717	CcSEcCtD
Fluticasone Propionate—Infection—Irbesartan—type 2 diabetes mellitus	0.000107	0.000716	CcSEcCtD
Fluticasone Propionate—Malnutrition—Ramipril—type 2 diabetes mellitus	0.000106	0.000713	CcSEcCtD
Fluticasone Propionate—Erythema—Ramipril—type 2 diabetes mellitus	0.000106	0.000713	CcSEcCtD
Fluticasone Propionate—Pain—Orlistat—type 2 diabetes mellitus	0.000106	0.000709	CcSEcCtD
Fluticasone Propionate—Chest pain—Losartan—type 2 diabetes mellitus	0.000106	0.000708	CcSEcCtD
Fluticasone Propionate—Arthralgia—Losartan—type 2 diabetes mellitus	0.000106	0.000708	CcSEcCtD
Fluticasone Propionate—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000106	0.000707	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000105	0.000707	CcSEcCtD
Fluticasone Propionate—Anxiety—Losartan—type 2 diabetes mellitus	0.000105	0.000705	CcSEcCtD
Fluticasone Propionate—Tachycardia—Irbesartan—type 2 diabetes mellitus	0.000105	0.000703	CcSEcCtD
Fluticasone Propionate—Rash—Bromocriptine—type 2 diabetes mellitus	0.000105	0.000701	CcSEcCtD
Fluticasone Propionate—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000105	0.0007	CcSEcCtD
Fluticasone Propionate—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.000104	0.0007	CcSEcCtD
Fluticasone Propionate—Discomfort—Losartan—type 2 diabetes mellitus	0.000104	0.000699	CcSEcCtD
Fluticasone Propionate—Headache—Bromocriptine—type 2 diabetes mellitus	0.000104	0.000697	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000104	0.000696	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000104	0.000696	CcSEcCtD
Fluticasone Propionate—Dry mouth—Losartan—type 2 diabetes mellitus	0.000103	0.000692	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000102	0.000686	CcSEcCtD
Fluticasone Propionate—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000102	0.000685	CcSEcCtD
Fluticasone Propionate—Triamcinolone—NR3C1—type 2 diabetes mellitus	0.000102	0.0224	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000102	0.000683	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000102	0.000681	CcSEcCtD
Fluticasone Propionate—Oedema—Losartan—type 2 diabetes mellitus	0.000101	0.000678	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000101	0.000678	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000101	0.000678	CcSEcCtD
Fluticasone Propionate—Infection—Losartan—type 2 diabetes mellitus	0.000101	0.000674	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.0001	0.000672	CcSEcCtD
Fluticasone Propionate—Tremor—Ramipril—type 2 diabetes mellitus	9.96e-05	0.000668	CcSEcCtD
Fluticasone Propionate—Urticaria—Valsartan—type 2 diabetes mellitus	9.94e-05	0.000666	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Losartan—type 2 diabetes mellitus	9.93e-05	0.000665	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Valsartan—type 2 diabetes mellitus	9.89e-05	0.000663	CcSEcCtD
Fluticasone Propionate—Tachycardia—Losartan—type 2 diabetes mellitus	9.88e-05	0.000662	CcSEcCtD
Fluticasone Propionate—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	9.87e-05	0.000661	CcSEcCtD
Fluticasone Propionate—Nausea—Bromocriptine—type 2 diabetes mellitus	9.86e-05	0.00066	CcSEcCtD
Fluticasone Propionate—Urticaria—Orlistat—type 2 diabetes mellitus	9.83e-05	0.000658	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	9.8e-05	0.000657	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000655	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Orlistat—type 2 diabetes mellitus	9.78e-05	0.000655	CcSEcCtD
Fluticasone Propionate—Agitation—Ramipril—type 2 diabetes mellitus	9.77e-05	0.000655	CcSEcCtD
Fluticasone Propionate—Angioedema—Ramipril—type 2 diabetes mellitus	9.72e-05	0.000651	CcSEcCtD
Fluticasone Propionate—Vomiting—Glyburide—type 2 diabetes mellitus	9.65e-05	0.000646	CcSEcCtD
Fluticasone Propionate—Pruritus—Gliclazide—type 2 diabetes mellitus	9.64e-05	0.000646	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NOS2—type 2 diabetes mellitus	9.6e-05	0.0211	CrCbGaD
Fluticasone Propionate—Malaise—Ramipril—type 2 diabetes mellitus	9.59e-05	0.000643	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Irbesartan—type 2 diabetes mellitus	9.59e-05	0.000643	CcSEcCtD
Fluticasone Propionate—Rash—Glyburide—type 2 diabetes mellitus	9.57e-05	0.000641	CcSEcCtD
Fluticasone Propionate—Dermatitis—Glyburide—type 2 diabetes mellitus	9.56e-05	0.00064	CcSEcCtD
Fluticasone Propionate—Headache—Glyburide—type 2 diabetes mellitus	9.5e-05	0.000637	CcSEcCtD
Fluticasone Propionate—Palpitations—Ramipril—type 2 diabetes mellitus	9.4e-05	0.00063	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Metformin—type 2 diabetes mellitus	9.39e-05	0.000629	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Gliclazide—type 2 diabetes mellitus	9.32e-05	0.000625	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	9.32e-05	0.000624	CcSEcCtD
Fluticasone Propionate—Cough—Ramipril—type 2 diabetes mellitus	9.28e-05	0.000622	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	9.22e-05	0.000618	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Valsartan—type 2 diabetes mellitus	9.22e-05	0.000618	CcSEcCtD
Fluticasone Propionate—Pain—Irbesartan—type 2 diabetes mellitus	9.2e-05	0.000616	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Orlistat—type 2 diabetes mellitus	9.11e-05	0.000611	CcSEcCtD
Fluticasone Propionate—Urticaria—Metformin—type 2 diabetes mellitus	9.05e-05	0.000607	CcSEcCtD
Fluticasone Propionate—Arthralgia—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000607	CcSEcCtD
Fluticasone Propionate—Chest pain—Ramipril—type 2 diabetes mellitus	9.05e-05	0.000607	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Losartan—type 2 diabetes mellitus	9.02e-05	0.000605	CcSEcCtD
Fluticasone Propionate—Anxiety—Ramipril—type 2 diabetes mellitus	9.02e-05	0.000605	CcSEcCtD
Fluticasone Propionate—Nausea—Glyburide—type 2 diabetes mellitus	9.01e-05	0.000604	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Metformin—type 2 diabetes mellitus	9.01e-05	0.000604	CcSEcCtD
Fluticasone Propionate—Dizziness—Gliclazide—type 2 diabetes mellitus	9.01e-05	0.000604	CcSEcCtD
Fluticasone Propionate—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	8.99e-05	0.000602	CcSEcCtD
Fluticasone Propionate—Discomfort—Ramipril—type 2 diabetes mellitus	8.95e-05	0.000599	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	8.86e-05	0.000594	CcSEcCtD
Fluticasone Propionate—Pruritus—Valsartan—type 2 diabetes mellitus	8.86e-05	0.000593	CcSEcCtD
Fluticasone Propionate—Dry mouth—Ramipril—type 2 diabetes mellitus	8.86e-05	0.000593	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	8.8e-05	0.000589	CcSEcCtD
Fluticasone Propionate—Fluticasone furoate—CYP3A4—type 2 diabetes mellitus	8.79e-05	0.0193	CrCbGaD
Fluticasone Propionate—Pruritus—Orlistat—type 2 diabetes mellitus	8.75e-05	0.000586	CcSEcCtD
Fluticasone Propionate—Oedema—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000582	CcSEcCtD
Fluticasone Propionate—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	8.68e-05	0.000582	CcSEcCtD
Fluticasone Propionate—Vomiting—Gliclazide—type 2 diabetes mellitus	8.66e-05	0.00058	CcSEcCtD
Fluticasone Propionate—Pain—Losartan—type 2 diabetes mellitus	8.66e-05	0.00058	CcSEcCtD
Fluticasone Propionate—Rash—Gliclazide—type 2 diabetes mellitus	8.59e-05	0.000576	CcSEcCtD
Fluticasone Propionate—Dermatitis—Gliclazide—type 2 diabetes mellitus	8.58e-05	0.000575	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Valsartan—type 2 diabetes mellitus	8.56e-05	0.000574	CcSEcCtD
Fluticasone Propionate—Urticaria—Irbesartan—type 2 diabetes mellitus	8.55e-05	0.000573	CcSEcCtD
Fluticasone Propionate—Headache—Gliclazide—type 2 diabetes mellitus	8.53e-05	0.000572	CcSEcCtD
Fluticasone Propionate—Nervous system disorder—Ramipril—type 2 diabetes mellitus	8.51e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Irbesartan—type 2 diabetes mellitus	8.5e-05	0.00057	CcSEcCtD
Fluticasone Propionate—Tachycardia—Ramipril—type 2 diabetes mellitus	8.47e-05	0.000568	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Orlistat—type 2 diabetes mellitus	8.46e-05	0.000567	CcSEcCtD
Fluticasone Propionate—Skin disorder—Ramipril—type 2 diabetes mellitus	8.43e-05	0.000565	CcSEcCtD
Fluticasone Propionate—Betamethasone—NR3C1—type 2 diabetes mellitus	8.35e-05	0.0184	CrCbGaD
Fluticasone Propionate—Feeling abnormal—Losartan—type 2 diabetes mellitus	8.34e-05	0.000559	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	8.28e-05	0.000555	CcSEcCtD
Fluticasone Propionate—Dizziness—Valsartan—type 2 diabetes mellitus	8.28e-05	0.000555	CcSEcCtD
Fluticasone Propionate—Dizziness—Orlistat—type 2 diabetes mellitus	8.18e-05	0.000548	CcSEcCtD
Fluticasone Propionate—Nausea—Gliclazide—type 2 diabetes mellitus	8.09e-05	0.000542	CcSEcCtD
Fluticasone Propionate—Pruritus—Metformin—type 2 diabetes mellitus	8.06e-05	0.00054	CcSEcCtD
Fluticasone Propionate—Urticaria—Losartan—type 2 diabetes mellitus	8.04e-05	0.000539	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Losartan—type 2 diabetes mellitus	8e-05	0.000536	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Losartan—type 2 diabetes mellitus	8e-05	0.000536	CcSEcCtD
Fluticasone Propionate—Vomiting—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000533	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	7.92e-05	0.000531	CcSEcCtD
Fluticasone Propionate—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	7.91e-05	0.00053	CcSEcCtD
Fluticasone Propionate—Rash—Valsartan—type 2 diabetes mellitus	7.89e-05	0.000529	CcSEcCtD
Fluticasone Propionate—Dermatitis—Valsartan—type 2 diabetes mellitus	7.88e-05	0.000528	CcSEcCtD
Fluticasone Propionate—Vomiting—Orlistat—type 2 diabetes mellitus	7.86e-05	0.000527	CcSEcCtD
Fluticasone Propionate—Headache—Valsartan—type 2 diabetes mellitus	7.84e-05	0.000525	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Metformin—type 2 diabetes mellitus	7.8e-05	0.000523	CcSEcCtD
Fluticasone Propionate—Rash—Orlistat—type 2 diabetes mellitus	7.8e-05	0.000522	CcSEcCtD
Fluticasone Propionate—Dermatitis—Orlistat—type 2 diabetes mellitus	7.79e-05	0.000522	CcSEcCtD
Fluticasone Propionate—Headache—Orlistat—type 2 diabetes mellitus	7.75e-05	0.000519	CcSEcCtD
Fluticasone Propionate—Dyspnoea—Ramipril—type 2 diabetes mellitus	7.74e-05	0.000518	CcSEcCtD
Fluticasone Propionate—Alclometasone—CYP3A4—type 2 diabetes mellitus	7.72e-05	0.017	CrCbGaD
Fluticasone Propionate—Pruritus—Irbesartan—type 2 diabetes mellitus	7.61e-05	0.00051	CcSEcCtD
Fluticasone Propionate—Dizziness—Metformin—type 2 diabetes mellitus	7.54e-05	0.000505	CcSEcCtD
Fluticasone Propionate—Flunisolide—CYP3A4—type 2 diabetes mellitus	7.52e-05	0.0166	CrCbGaD
Fluticasone Propionate—Hypersensitivity—Losartan—type 2 diabetes mellitus	7.46e-05	0.0005	CcSEcCtD
Fluticasone Propionate—Nausea—Valsartan—type 2 diabetes mellitus	7.43e-05	0.000498	CcSEcCtD
Fluticasone Propionate—Paramethasone—CYP3A4—type 2 diabetes mellitus	7.42e-05	0.0163	CrCbGaD
Fluticasone Propionate—Diarrhoea—Irbesartan—type 2 diabetes mellitus	7.36e-05	0.000493	CcSEcCtD
Fluticasone Propionate—Nausea—Orlistat—type 2 diabetes mellitus	7.35e-05	0.000492	CcSEcCtD
Fluticasone Propionate—Fluorometholone—CYP3A4—type 2 diabetes mellitus	7.25e-05	0.016	CrCbGaD
Fluticasone Propionate—Vomiting—Metformin—type 2 diabetes mellitus	7.25e-05	0.000486	CcSEcCtD
Fluticasone Propionate—Rash—Metformin—type 2 diabetes mellitus	7.19e-05	0.000482	CcSEcCtD
Fluticasone Propionate—Dermatitis—Metformin—type 2 diabetes mellitus	7.18e-05	0.000481	CcSEcCtD
Fluticasone Propionate—Pruritus—Losartan—type 2 diabetes mellitus	7.16e-05	0.00048	CcSEcCtD
Fluticasone Propionate—Feeling abnormal—Ramipril—type 2 diabetes mellitus	7.15e-05	0.000479	CcSEcCtD
Fluticasone Propionate—Headache—Metformin—type 2 diabetes mellitus	7.14e-05	0.000478	CcSEcCtD
Fluticasone Propionate—Dizziness—Irbesartan—type 2 diabetes mellitus	7.11e-05	0.000477	CcSEcCtD
Fluticasone Propionate—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	7.1e-05	0.000476	CcSEcCtD
Fluticasone Propionate—Methylprednisolone—CYP3A4—type 2 diabetes mellitus	7.01e-05	0.0154	CrCbGaD
Fluticasone Propionate—Diarrhoea—Losartan—type 2 diabetes mellitus	6.93e-05	0.000464	CcSEcCtD
Fluticasone Propionate—Urticaria—Ramipril—type 2 diabetes mellitus	6.9e-05	0.000462	CcSEcCtD
Fluticasone Propionate—Body temperature increased—Ramipril—type 2 diabetes mellitus	6.86e-05	0.00046	CcSEcCtD
Fluticasone Propionate—Abdominal pain—Ramipril—type 2 diabetes mellitus	6.86e-05	0.00046	CcSEcCtD
Fluticasone Propionate—Vomiting—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000458	CcSEcCtD
Fluticasone Propionate—Rash—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000454	CcSEcCtD
Fluticasone Propionate—Dermatitis—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000454	CcSEcCtD
Fluticasone Propionate—Nausea—Metformin—type 2 diabetes mellitus	6.77e-05	0.000454	CcSEcCtD
Fluticasone Propionate—Headache—Irbesartan—type 2 diabetes mellitus	6.74e-05	0.000451	CcSEcCtD
Fluticasone Propionate—Dizziness—Losartan—type 2 diabetes mellitus	6.69e-05	0.000449	CcSEcCtD
Fluticasone Propionate—Vomiting—Losartan—type 2 diabetes mellitus	6.44e-05	0.000431	CcSEcCtD
Fluticasone Propionate—Hypersensitivity—Ramipril—type 2 diabetes mellitus	6.4e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Nausea—Irbesartan—type 2 diabetes mellitus	6.39e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Rash—Losartan—type 2 diabetes mellitus	6.38e-05	0.000428	CcSEcCtD
Fluticasone Propionate—Dermatitis—Losartan—type 2 diabetes mellitus	6.38e-05	0.000427	CcSEcCtD
Fluticasone Propionate—Dexamethasone—ABCC2—type 2 diabetes mellitus	6.37e-05	0.014	CrCbGaD
Fluticasone Propionate—Headache—Losartan—type 2 diabetes mellitus	6.34e-05	0.000425	CcSEcCtD
Fluticasone Propionate—Pruritus—Ramipril—type 2 diabetes mellitus	6.14e-05	0.000411	CcSEcCtD
Fluticasone Propionate—Nausea—Losartan—type 2 diabetes mellitus	6.01e-05	0.000403	CcSEcCtD
Fluticasone Propionate—Diarrhoea—Ramipril—type 2 diabetes mellitus	5.94e-05	0.000398	CcSEcCtD
Fluticasone Propionate—Triamcinolone—CYP3A4—type 2 diabetes mellitus	5.91e-05	0.013	CrCbGaD
Fluticasone Propionate—Triamcinolone—PTGS2—type 2 diabetes mellitus	5.78e-05	0.0127	CrCbGaD
Fluticasone Propionate—Dizziness—Ramipril—type 2 diabetes mellitus	5.74e-05	0.000385	CcSEcCtD
Fluticasone Propionate—Vomiting—Ramipril—type 2 diabetes mellitus	5.52e-05	0.00037	CcSEcCtD
Fluticasone Propionate—Rash—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000367	CcSEcCtD
Fluticasone Propionate—Dermatitis—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000366	CcSEcCtD
Fluticasone Propionate—Headache—Ramipril—type 2 diabetes mellitus	5.44e-05	0.000364	CcSEcCtD
Fluticasone Propionate—Nausea—Ramipril—type 2 diabetes mellitus	5.16e-05	0.000345	CcSEcCtD
Fluticasone Propionate—Dexamethasone—NR3C1—type 2 diabetes mellitus	4.86e-05	0.0107	CrCbGaD
Fluticasone Propionate—Betamethasone—CYP3A4—type 2 diabetes mellitus	4.84e-05	0.0107	CrCbGaD
Fluticasone Propionate—Betamethasone—PTGS2—type 2 diabetes mellitus	4.74e-05	0.0104	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP2E1—type 2 diabetes mellitus	4.47e-05	0.00984	CrCbGaD
Fluticasone Propionate—Dexamethasone—CYP3A4—type 2 diabetes mellitus	2.81e-05	0.0062	CrCbGaD
Fluticasone Propionate—Dexamethasone—PTGS2—type 2 diabetes mellitus	2.76e-05	0.00607	CrCbGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPP2CA—type 2 diabetes mellitus	9.95e-06	0.00014	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP2E1—type 2 diabetes mellitus	9.94e-06	0.00014	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	9.86e-06	0.000139	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	9.86e-06	0.000139	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	9.83e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC2A1—type 2 diabetes mellitus	9.82e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP1A2—type 2 diabetes mellitus	9.82e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GLP1R—type 2 diabetes mellitus	9.82e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—C3—type 2 diabetes mellitus	9.77e-06	0.000138	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—GNB3—type 2 diabetes mellitus	9.74e-06	0.000137	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AVP—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP3—type 2 diabetes mellitus	9.61e-06	0.000135	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CYP3A4—type 2 diabetes mellitus	9.58e-06	0.000135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF2—type 2 diabetes mellitus	9.57e-06	0.000135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—MTHFR—type 2 diabetes mellitus	9.55e-06	0.000135	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	9.53e-06	0.000134	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	9.43e-06	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GCG—type 2 diabetes mellitus	9.42e-06	0.000133	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—SLC2A4—type 2 diabetes mellitus	9.42e-06	0.000133	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARA—type 2 diabetes mellitus	9.37e-06	0.000132	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	9.35e-06	0.000132	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	9.35e-06	0.000132	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—HIF1A—type 2 diabetes mellitus	9.32e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS2—type 2 diabetes mellitus	9.3e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOB—type 2 diabetes mellitus	9.29e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AGT—type 2 diabetes mellitus	9.29e-06	0.000131	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.25e-06	0.00013	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A2—type 2 diabetes mellitus	9.17e-06	0.000129	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.14e-06	0.000129	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CALM1—type 2 diabetes mellitus	9.13e-06	0.000129	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—LEP—type 2 diabetes mellitus	9.1e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOE—type 2 diabetes mellitus	9.1e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AGT—type 2 diabetes mellitus	9.07e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPP2CA—type 2 diabetes mellitus	9.06e-06	0.000128	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—APOA1—type 2 diabetes mellitus	9e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CPT1A—type 2 diabetes mellitus	8.98e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTR—type 2 diabetes mellitus	8.98e-06	0.000127	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—CALM1—type 2 diabetes mellitus	8.92e-06	0.000126	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	8.92e-06	0.000126	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOE—type 2 diabetes mellitus	8.89e-06	0.000125	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LPL—type 2 diabetes mellitus	8.87e-06	0.000125	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NAMPT—type 2 diabetes mellitus	8.81e-06	0.000124	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—APOA1—type 2 diabetes mellitus	8.79e-06	0.000124	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCK—type 2 diabetes mellitus	8.76e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LIPC—type 2 diabetes mellitus	8.76e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HBA1—type 2 diabetes mellitus	8.76e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP11A1—type 2 diabetes mellitus	8.7e-06	0.000123	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—ADCY5—type 2 diabetes mellitus	8.68e-06	0.000122	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PRKCB—type 2 diabetes mellitus	8.58e-06	0.000121	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC9A1—type 2 diabetes mellitus	8.55e-06	0.00012	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARA—type 2 diabetes mellitus	8.53e-06	0.00012	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CETP—type 2 diabetes mellitus	8.45e-06	0.000119	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.32e-06	0.000117	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	8.23e-06	0.000116	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	8.23e-06	0.000116	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.17e-06	0.000115	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARGC1A—type 2 diabetes mellitus	8.12e-06	0.000114	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GNB3—type 2 diabetes mellitus	8.12e-06	0.000114	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IRS1—type 2 diabetes mellitus	8.12e-06	0.000114	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—HMOX1—type 2 diabetes mellitus	8.08e-06	0.000114	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—C3—type 2 diabetes mellitus	7.98e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CAT—type 2 diabetes mellitus	7.97e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	7.95e-06	0.000112	CbGpPWpGaD
Fluticasone Propionate—NR3C2—Gene Expression—AKT1—type 2 diabetes mellitus	7.91e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PSMD6—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SNAP25—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SREBF1—type 2 diabetes mellitus	7.85e-06	0.000111	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—INS—type 2 diabetes mellitus	7.77e-06	0.00011	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PPARG—type 2 diabetes mellitus	7.74e-06	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOB—type 2 diabetes mellitus	7.74e-06	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CTGF—type 2 diabetes mellitus	7.71e-06	0.000109	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	7.7e-06	0.000108	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CCL2—type 2 diabetes mellitus	7.65e-06	0.000108	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMGCR—type 2 diabetes mellitus	7.64e-06	0.000108	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—HIF1A—type 2 diabetes mellitus	7.62e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS2—type 2 diabetes mellitus	7.6e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—INS—type 2 diabetes mellitus	7.59e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AGT—type 2 diabetes mellitus	7.59e-06	0.000107	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Hemostasis—AKT1—type 2 diabetes mellitus	7.55e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GSTM1—type 2 diabetes mellitus	7.53e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IGF1—type 2 diabetes mellitus	7.52e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT2—type 2 diabetes mellitus	7.51e-06	0.000106	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADRA2A—type 2 diabetes mellitus	7.48e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.46e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—LEP—type 2 diabetes mellitus	7.43e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOE—type 2 diabetes mellitus	7.43e-06	0.000105	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—LPL—type 2 diabetes mellitus	7.39e-06	0.000104	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.35e-06	0.000104	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	7.27e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	7.27e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ADCY5—type 2 diabetes mellitus	7.24e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—GPX1—type 2 diabetes mellitus	7.21e-06	0.000102	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP2E1—type 2 diabetes mellitus	7.18e-06	0.000101	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	7.14e-06	0.000101	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A1—type 2 diabetes mellitus	7.1e-06	0.0001	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP1A2—type 2 diabetes mellitus	7.1e-06	0.0001	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	7.09e-06	9.98e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—PPARG—type 2 diabetes mellitus	7.05e-06	9.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CD36—type 2 diabetes mellitus	7.02e-06	9.89e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.01e-06	9.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—ALB—type 2 diabetes mellitus	6.96e-06	9.81e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPP2CA—type 2 diabetes mellitus	6.93e-06	9.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CYP3A4—type 2 diabetes mellitus	6.93e-06	9.76e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	6.82e-06	9.6e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NOS3—type 2 diabetes mellitus	6.82e-06	9.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GCG—type 2 diabetes mellitus	6.81e-06	9.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—SLC2A4—type 2 diabetes mellitus	6.81e-06	9.59e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	6.76e-06	9.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	6.76e-06	9.52e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	6.76e-06	9.52e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PIK3R1—type 2 diabetes mellitus	6.66e-06	9.38e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—NOS3—type 2 diabetes mellitus	6.66e-06	9.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—MTHFR—type 2 diabetes mellitus	6.65e-06	9.37e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IRS1—type 2 diabetes mellitus	6.63e-06	9.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARA—type 2 diabetes mellitus	6.53e-06	9.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	6.48e-06	9.13e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	6.48e-06	9.13e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—RELA—type 2 diabetes mellitus	6.42e-06	9.04e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—INS—type 2 diabetes mellitus	6.35e-06	8.95e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—SERPINE1—type 2 diabetes mellitus	6.35e-06	8.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AGT—type 2 diabetes mellitus	6.32e-06	8.91e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.25e-06	8.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	6.24e-06	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	6.24e-06	8.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—CALM1—type 2 diabetes mellitus	6.22e-06	8.76e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOE—type 2 diabetes mellitus	6.2e-06	8.73e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.14e-06	8.65e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.14e-06	8.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	6.13e-06	8.63e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—APOA1—type 2 diabetes mellitus	6.12e-06	8.63e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.11e-06	8.61e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—PTGS2—type 2 diabetes mellitus	6.09e-06	8.58e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	6.03e-06	8.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	6.03e-06	8.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	6.03e-06	8.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARGC1A—type 2 diabetes mellitus	5.87e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GNB3—type 2 diabetes mellitus	5.87e-06	8.27e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—HMOX1—type 2 diabetes mellitus	5.84e-06	8.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	5.83e-06	8.22e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.79e-06	8.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CAT—type 2 diabetes mellitus	5.76e-06	8.12e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	5.67e-06	7.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOB—type 2 diabetes mellitus	5.6e-06	7.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.57e-06	7.84e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.57e-06	7.84e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—MMP9—type 2 diabetes mellitus	5.47e-06	7.7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GSTM1—type 2 diabetes mellitus	5.44e-06	7.67e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—NFKB1—type 2 diabetes mellitus	5.41e-06	7.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PPARG—type 2 diabetes mellitus	5.4e-06	7.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—LPL—type 2 diabetes mellitus	5.34e-06	7.53e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	5.31e-06	7.47e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—INS—type 2 diabetes mellitus	5.29e-06	7.46e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—RELA—type 2 diabetes mellitus	5.24e-06	7.38e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ADCY5—type 2 diabetes mellitus	5.23e-06	7.37e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—GPX1—type 2 diabetes mellitus	5.21e-06	7.34e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	5.12e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	5.12e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	5.12e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	5.12e-06	7.22e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CD36—type 2 diabetes mellitus	5.08e-06	7.15e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—SRC—type 2 diabetes mellitus	5.04e-06	7.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPP2CA—type 2 diabetes mellitus	5.01e-06	7.06e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	4.91e-06	6.92e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.91e-06	6.92e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—ALB—type 2 diabetes mellitus	4.85e-06	6.84e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Gene Expression—AKT1—type 2 diabetes mellitus	4.82e-06	6.79e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—MTHFR—type 2 diabetes mellitus	4.81e-06	6.78e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—CASP3—type 2 diabetes mellitus	4.73e-06	6.66e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARA—type 2 diabetes mellitus	4.72e-06	6.65e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.7e-06	6.62e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—NOS3—type 2 diabetes mellitus	4.64e-06	6.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PIK3R1—type 2 diabetes mellitus	4.64e-06	6.54e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AGT—type 2 diabetes mellitus	4.57e-06	6.44e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	4.57e-06	6.43e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—TGFB1—type 2 diabetes mellitus	4.51e-06	6.35e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—CALM1—type 2 diabetes mellitus	4.49e-06	6.33e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOE—type 2 diabetes mellitus	4.48e-06	6.31e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.47e-06	6.29e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—APOA1—type 2 diabetes mellitus	4.43e-06	6.24e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.42e-06	6.23e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—EGFR—type 2 diabetes mellitus	4.42e-06	6.23e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.33e-06	6.1e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	4.26e-06	6.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—PTGS2—type 2 diabetes mellitus	4.25e-06	5.98e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	4.18e-06	5.88e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	4.18e-06	5.88e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—SRC—type 2 diabetes mellitus	4.12e-06	5.8e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	4.1e-06	5.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	4.07e-06	5.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	4.07e-06	5.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	4.07e-06	5.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	4.05e-06	5.7e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.01e-06	5.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	3.97e-06	5.6e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	3.93e-06	5.53e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PPARG—type 2 diabetes mellitus	3.9e-06	5.49e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—INS—type 2 diabetes mellitus	3.83e-06	5.39e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.68e-06	5.19e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	3.65e-06	5.14e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	3.65e-06	5.14e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	3.65e-06	5.14e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.61e-06	5.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	3.58e-06	5.05e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	3.55e-06	5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—ALB—type 2 diabetes mellitus	3.51e-06	4.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	3.48e-06	4.9e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—IL6—type 2 diabetes mellitus	3.4e-06	4.78e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—NOS3—type 2 diabetes mellitus	3.36e-06	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PIK3R1—type 2 diabetes mellitus	3.36e-06	4.73e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	3.34e-06	4.7e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	3.3e-06	4.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	3.3e-06	4.65e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	3.17e-06	4.46e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	3.17e-06	4.46e-05	CbGpPWpGaD
Fluticasone Propionate—PGR—Signaling Pathways—AKT1—type 2 diabetes mellitus	3.13e-06	4.41e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—PTGS2—type 2 diabetes mellitus	3.07e-06	4.32e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Metabolism—AKT1—type 2 diabetes mellitus	3.06e-06	4.31e-05	CbGpPWpGaD
Fluticasone Propionate—NR3C1—Gene Expression—AKT1—type 2 diabetes mellitus	2.79e-06	3.92e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—IL6—type 2 diabetes mellitus	2.77e-06	3.91e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	2.73e-06	3.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	2.73e-06	3.84e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	2.72e-06	3.83e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	2.68e-06	3.77e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	2.6e-06	3.66e-05	CbGpPWpGaD
Fluticasone Propionate—PLA2G4A—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.56e-06	3.61e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	2.53e-06	3.56e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	2.48e-06	3.5e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	2.43e-06	3.43e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	2.42e-06	3.41e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	2.36e-06	3.32e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	2.33e-06	3.28e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	2.24e-06	3.15e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	2.19e-06	3.09e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A7—Metabolism—AKT1—type 2 diabetes mellitus	2.13e-06	3.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	2.12e-06	2.99e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	2.09e-06	2.94e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	2.08e-06	2.93e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	2.06e-06	2.9e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.81e-06	2.55e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.78e-06	2.51e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.63e-06	2.3e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.56e-06	2.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.56e-06	2.2e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A5—Metabolism—AKT1—type 2 diabetes mellitus	1.54e-06	2.17e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.43e-06	2.01e-05	CbGpPWpGaD
Fluticasone Propionate—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	7.17e-07	1.01e-05	CbGpPWpGaD
